Now there are even "land and other projects". Is there no more space for biomedical industry in Shanghai? "Old Almanac"

Release time:Apr 24, 2024 05:12 AM

One month after Chi-Med's fruquintinib was approved in the United States and the first prescription was issued, on December 8, as one of Shanghai's major strategic emerging industry projects, the "He-Medical" project in Zhangjiang Innovative Drug Industry Base Huang Medical Innovative Drug Production Base" was officially completed and put into operation.

In the past, there was a voice that believed that Shanghai did not have more space for the biomedical industry. A reporter from Jiefang Daily and Shangguan News recently learned in an interview that with the release of more biomedical industry space in Shanghai, it used to be "land for projects", but now it is not only "there is no shortage of space for good projects", but also "land, etc." Project" new atmosphere.

In order to accelerate the creation of a global biomedical R&D economy and industrialization highland and strengthen the integrated layout of "Zhangjiang R&D and Shanghai Manufacturing", the "Shanghai Action Plan to Accelerate the Construction of Biomedical Intelligent Manufacturing Space" was recently released. By the end of 2024, the construction of biomedical standard factories will begin. The total scale is nearly 5 million square meters. Among them, Zhangjiang Science City occupies nearly 800,000 square meters.

Not far from Chi-Med’s innovative drug production base is the first phase construction site of the Intelligent Manufacturing Space Zhangjiang Innovative Drug Industrialization Platform. The reporter saw at the scene that a modern standard factory building has taken shape.

"It will provide 59,000 square meters of space and is expected to be completed in March next year. It can meet both research and development and production needs. It has complete supporting facilities and meets the development needs of modern biopharmaceutical companies. Currently, there are more than 10 intended customers under negotiation. " Zhuang Jie, manager of the administrative and human resources department of Shanghai Zhangjiang Innovative Drug Industry Base Construction Co., Ltd. told reporters.

The construction site of the first phase of the Zhangjiang innovative drug industrialization platform. Photo by Huang Haihua

On Xinwo Road, close to Gubo Road and Gunn Road, the reporter saw that workers had just completed piling on the construction site of the first and second phases of the intelligent manufacturing space and biomedical standard factory building. In a large open space on Gubo Road near Kangxin Highway, the third and fourth phases of the Intelligent Manufacturing Space·Biomedicine Standard Factory Building will start construction at the end of December. Along Gubo Road to the west, there are 200 acres of intelligent manufacturing space and biomedical standard factory buildings planned to be constructed in batches in 2024 and 2025. Everywhere the reporter went, there was vitality in the new space of the biomedical industry.

Chi-Med's senior vice president Cui Yuxing said in a previous interview with a reporter from Liberation Daily and Shangguan News that they once thought that there was no land in Pudong to implement biopharmaceutical industry projects. After a communication with the government department, they learned that Shanghai was planning Based on the new industrial map, the land was obtained and construction started in the same year, leaving the innovative drug production base project in Shanghai.

After completion, Chi-Med's innovative drug production base will cover an area of ​​43 acres, with a construction area of ​​nearly 55,000 square meters, and an annual production capacity of 250 million tablets and 550 million capsules. "It is expected that the production capacity will be increased by more than 5 times and commercial drugs will be supplied around 2025." Chi-Med's CEO and Chief Scientific Officer Su Weiguo said that this will help the company develop from a biotechnology company to a profitable biopharmaceutical company. .

It is understood that during the 14th Five-Year Plan period, 7 major projects of intelligent manufacturing space and biomedicine standard factories in Zhangjiang Innovative Pharmaceutical Industry Base are planned to be started, with a land area of ​​more than 400 acres and an investment intensity of nearly 7 billion yuan.

"Now there is more and more industrial space and more supply. It used to be 'land for projects and other projects', but now it is 'land and other projects'." Zhuang Jie told reporters.


Now there are even "land and other projects". Is there no more space for biomedical industry in Shanghai? "Old Almanac"
What domestic medical "important tools" did the General Secretary see in Shanghai?
What domestic medical "important tools" did the General Secretary see in Shanghai?

From November 28th to 29th, General Secretary Xi Jinping visited Shanghai for investigation and research, and came to the Shanghai Science and Technology Innovation Achievements Exhibition to learn about Shanghai's progress in building an international science and technology innovation center. In the Future Park of Zhangjiang Science City, the Shanghai Science and Technology Innovation Achievements Exhibition displays a number of important medical tools. They are all the results of research and development by Shanghai enterprises and universities and colleges. They have promoted the rapid development of the biomedical industry through independent innovation for people's life and health. Proton therapy accurately kills tumors. Proton therapy is one of the world's most advanced tumor radiotherapy methods and is known as the "tumor directional blasting artifact." Protons can concentrate the killing dose at the tumor tissue, and then the energy quickly returns to zero, stopping immediately, thereby protecting the normal tissue around the tumor and achieving precise attacks on the tumor. Compared with traditional radiotherapy

How far are we from universal AI robots? , China Electronics Technology Corporation releases its first generation humanoid robot
How far are we from universal AI robots? , China Electronics Technology Corporation releases its first generation humanoid robot

With the advent of Tesla's humanoid robot "Optimus Prime" and the large artificial intelligence model ChatGPT, general-purpose humanoid robots have become a popular track in the world's cutting-edge technology. At the 27th China Small Motor Technology Seminar and Exhibition held in Shanghai recently, the first-generation humanoid robot developed by the 21st Research Institute of China Electronics Technology Group Corporation was unveiled, attracting attention in the industry. How far away are universal humanoid robots from our lives? Dr. Jiang Zhiyong, head of humanoid robot research and development at the 21st Institute of China Electronics Technology, believes that at present, many humanoid robots that have been released by domestic companies are basically in the same level range, with little difference between each other. They are all still a long way away from commercially available general-purpose intelligent services. distance. In the future, domestic enterprises must continue to accumulate technology and invest in talents in order to achieve "change from quantity to quality"

New Academician’s “Sketch” | Shen Weixiao’s Smile
New Academician’s “Sketch” | Shen Weixiao’s Smile

"There is a kind of mathematician who is very meticulous in playing chess, and I belong to another kind, who is a complete mess in playing chess." Shen Weixiao, a professor at Fudan University's Shanghai Mathematics Center and School of Mathematical Sciences, finished his words and laughed himself. 48-year-old Shen Weixiao loves to laugh, and since his name is a homophony of "smile", he has a nickname among his students: "Teacher Smile". On November 23, the newly promoted academician of the Chinese Academy of Sciences smiled from time to time during an exclusive interview with a reporter from Liberation Daily and Shangguan News. [Confident Smile] When learning mathematics, which is more important, interest or talent? Shen Weixiao's answer is that both are indispensable. Shen Weixiao grew up in a rural area. He went to school at the age of 5 and went to college at the age of 16. He participated in the junior high school and high school mathematics leagues and won the first prize in Anhui Province respectively. There were no training classes at that time, so the math teacher brought him a tutorial book from the city.

How difficult is it for domestic companies to develop automotive chips? Experts recommend speeding up the development of quality and reliability standards
How difficult is it for domestic companies to develop automotive chips? Experts recommend speeding up the development of quality and reliability standards

"When there was a shortage of automotive chips in 2021, the leader of the Ministry of Industry and Information Technology convened a meeting of experts from the automotive and semiconductor industries. At the meeting, he asked us: After the 'core shortage' passes, will the two industries still discuss automotive chips together?" Held yesterday At the second 100-person Automotive Chip Forum "Science and Technology Innovation in China", Lu Wancheng, deputy chief engineer of United Automotive Electronics Co., Ltd., recalled in his speech. Indeed, that "chip shortage" triggered Chinese people's attention to the automotive chip industry. Today, two years later, experts from the automotive and chip industries have gathered to continue discussing this important issue. Laying out and building an automotive chip closed-loop ecological chain. As one of the series of activities of the 6th Yangtze River Delta Science and Technology Achievements Trade Expo, this forum focuses on the automotive chip industry chain and cutting-edge development directions, aiming to gather the Yangtze River Delta’s scientific and technological innovation resources and attract automobile and integrated

Shanghai strengthens "whole-process innovation" and "invests first and shares later" to promote breakthroughs in laser core technology
Shanghai strengthens "whole-process innovation" and "invests first and shares later" to promote breakthroughs in laser core technology

At the beginning of this year, Dr. Dong Yongjun returned to Shanghai, where he had been away for many years, and became the chairman of Xinfeirui Technology Co., Ltd. In 2014, this scientist who worked at the Shanghai Institute of Optics and Precision Mechanics of the Chinese Academy of Sciences went to Nanjing to establish Lite-On Optoelectronics Technology Co., Ltd. to develop laser crystal materials and other products. The reason why he returned to Shanghai to start his own business for the second time was that the Yangtze River Delta National Technology Innovation Center hired him as a project manager, responsible for the implementation of the "Laser Crystal Materials" project. The unit that implements this cutting-edge technology industrialization project is Xinfeirui Company. This start-up company settled in Baoshan District is a beneficiary of the "invest first, share later" reform pilot. According to the reform plan, Xinfeirui's scientific research and management team holds 90% of the shares, and the Shanghai Yangtze River Delta Technology Innovation Research Institute's shareholding platform holds 10%; Shanghai Changsan Institute and Shanghai Baoshan Technology Transfer Co., Ltd.